AAAAAA

   
Results: 1-13 |
Results: 13
SMOKING REDUCES STROKE SEVERITY
Authors: KAREPOV VG HESS Y BORNSTEIN NM KORCZYN AD
Citation: Vg. Karepov et al., SMOKING REDUCES STROKE SEVERITY, Annals of neurology, 44(3), 1998, pp. 112-112
SMOKING REDUCES STROKE SEVERITY
Authors: KAREPOV VG HASS Y BORNSTEIN NM KORCZYN AD
Citation: Vg. Karepov et al., SMOKING REDUCES STROKE SEVERITY, Neurology, 50(4), 1998, pp. 2087-2087
FACTORS WHICH INFLUENCE IN-HOSPITAL MORTALITY AFTER ACUTE ISCHEMIC STROKE
Authors: KAREPOV VG SITNOV I TREVES TA BORNSTEIN NM
Citation: Vg. Karepov et al., FACTORS WHICH INFLUENCE IN-HOSPITAL MORTALITY AFTER ACUTE ISCHEMIC STROKE, Stroke, 28(1), 1997, pp. 38-38
THE TEL-AVIV-STROKE-REGISTRY - 3600 CONSECUTIVE PATIENTS
Authors: BORNSTEIN NM ARONOVICH BD KAREPOV VG GUR AY TREVES TA OVED M KORCZYN AD
Citation: Nm. Bornstein et al., THE TEL-AVIV-STROKE-REGISTRY - 3600 CONSECUTIVE PATIENTS, Stroke, 27(10), 1996, pp. 1770-1773
DOES THE PROFILE OF RISK-FACTORS OF STROKE INFLUENCE ASPIRIN FAILURE
Authors: KAREPOV VG BORNSTEIN NM HASS Y KORCZYN AD
Citation: Vg. Karepov et al., DOES THE PROFILE OF RISK-FACTORS OF STROKE INFLUENCE ASPIRIN FAILURE, Stroke, 27(1), 1996, pp. 25-25
WHAT FACTORS ARE RESPONSIBLE FOR ASPIRIN FAILURE
Authors: KAREPOV VG BORNSTEIN NM HASS Y KORCZYN AD
Citation: Vg. Karepov et al., WHAT FACTORS ARE RESPONSIBLE FOR ASPIRIN FAILURE, Neurology, 46(2), 1996, pp. 3097-3097
ASPIRIN PRETREATMENT DOES NOT DIMINISH THE SEVERITY OF 1ST-EVER ISCHEMIC STROKE
Authors: KAREPOV VG BORNSTEIN NM HASS Y TREVES TA KORCZYN AD
Citation: Vg. Karepov et al., ASPIRIN PRETREATMENT DOES NOT DIMINISH THE SEVERITY OF 1ST-EVER ISCHEMIC STROKE, Neurology, 45(4), 1995, pp. 241-241
FACTORS ASSOCIATED WITH FAILURE OF ASPIRIN TREATMENT - RESPONSE
Authors: TREVES TA BORNSTEIN NM KAREPOV VG KORCZYN AD
Citation: Ta. Treves et al., FACTORS ASSOCIATED WITH FAILURE OF ASPIRIN TREATMENT - RESPONSE, Stroke, 25(8), 1994, pp. 1702-1702
INTERRATER AGREEMENT IN EVALUATION OF STROKE PATIENTS WITH THE UNIFIED NEUROLOGICAL STROKE SCALE
Authors: TREVES TA KAREPOV VG ARONOVICH BD GORBULEV AY BORNSTEIN NM KORCZYN AD
Citation: Ta. Treves et al., INTERRATER AGREEMENT IN EVALUATION OF STROKE PATIENTS WITH THE UNIFIED NEUROLOGICAL STROKE SCALE, Stroke, 25(6), 1994, pp. 1263-1264
FAILURE OF ASPIRIN TREATMENT AFTER STROKE
Authors: BORNSTEIN NM KAREPOV VG ARONOVICH BD GORBULEV AY TREVES TA KORCZYN AD
Citation: Nm. Bornstein et al., FAILURE OF ASPIRIN TREATMENT AFTER STROKE, Stroke, 25(2), 1994, pp. 275-277
ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE
Authors: BORNSTEIN NM KAREPOV VG ARONOVICH BD GORBULEV AY KORCZYN AD
Citation: Nm. Bornstein et al., ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE, Stroke, 25(1), 1994, pp. 268-268
ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE
Authors: KAREPOV VG BORNSTEIN NM ARONOVICH BD GORBULEV AY KORCZYN AD
Citation: Vg. Karepov et al., ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE, Neurology, 44(4), 1994, pp. 10000271-10000271
FAILURE OF ASPIRIN TREATMENT AFTER STROKE
Authors: BORNSTEIN NM KAREPOV VG ARONOVICH BD GORBULEV AY TREVES TA KORCZYN AD
Citation: Nm. Bornstein et al., FAILURE OF ASPIRIN TREATMENT AFTER STROKE, Neurology, 44(4), 1994, pp. 10000288-10000288
Risultati: 1-13 |